MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SELLAS Life Sciences Group (SLS) Ownership - Who owns SELLAS Life Sciences Group?

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
13
Web
https://www.sellaslifesciences.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.68B
P/E Ratio
N/A
Total Cash
107.1M
Projected Growth
N/A
Total Debt
871K
Revenue
N/A
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash/Share
0.54
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SLS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for SLS
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
13
Web
https://www.sellaslifesciences.com